Patrick M. Sweeney & Associates’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$390K Hold
1,108
0.25% 102
2025
Q4
$363K Buy
1,108
+71
+7% +$22.5K 0.23% 105
2025
Q3
$293K Buy
1,037
+62
+6% +$18K 0.19% 125
2025
Q2
$291K Hold
975
0.2% 120
2025
Q1
$304K Hold
975
0.23% 110
2024
Q4
$254K Sell
975
-16
-2% -$4.75K 0.19% 124
2024
Q3
$319K Hold
991
0.23% 111
2024
Q2
$310K Hold
991
0.25% 99
2024
Q1
$282K Buy
991
+66
+7% +$19.3K 0.23% 105
2023
Q4
$266K Buy
+925
New +$252K 0.24% 96

Other funds holding AMGN

Patrick M. Sweeney & Associates's AMGN Position: Q1 2026 in Review

Patrick M. Sweeney & Associates held its Amgen (AMGN) position steady in Q1 2026 at 1,108 shares worth $390K. The position accounts for 0.25% of the portfolio, ranked #102.

Patrick M. Sweeney & Associates first reported a position in AMGN in Q4 2023 and has held it in 10 quarters since. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Patrick M. Sweeney & Associates held 1,108 shares of Amgen worth $390K as of Q1 2026.
  • Patrick M. Sweeney & Associates left its Amgen share count unchanged in Q1 2026.
  • Amgen made up 0.25% of Patrick M. Sweeney & Associates's portfolio in Q1 2026, its #102 holding.
  • Patrick M. Sweeney & Associates first reported a position in Amgen in Q4 2023 and has held it in 10 quarters since.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Patrick M. Sweeney & Associates's 13F filing for Q1 2026, filed 7 May 2026.